ABCB5:关键调节剂 链接干细胞可塑性,瘤微环境和皮肤黑色素瘤治疗阻力
Andreea Cătălina Tinca1,2, Adrian Horațiu Sabău1,2, Andreea Raluca Cozac-Szoke1,2
1Pathophysiology Department, George Emil Palade University of Medicine, Pharmacy, Science and Technology, 540142 Târgu Mureș, Romania.
Cancers
|February 13, 2026
概括
ABCB5是一种与抗药性和黑色素瘤免疫逃脱相关的基因,促进瘤进展和预后不佳. 准ABCB5可能为这种侵袭性皮肤癌提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 皮肤黑色素瘤是一种侵袭性皮肤癌.
- 瘤微环境和免疫调节是治疗策略的关键.
- 结合ATP的磁带载体和与干相关的途径会影响药物反应和免疫逃逸.
研究的目的:
- 审查黑色素瘤进展和治疗耐药性的分子和微环境机制.
- 为了突出ABCB5在黑色素瘤中的作用.
- 评估ABCB5作为潜在的生物标志物和治疗点.
主要方法:
- 对黑色素瘤进展,治疗耐药性和免疫调节研究的文献综述.
- 分析ABCB5及其异型在黑色素瘤类干细胞中的作用.
- 整合有关ABCB5相关途径和微环境因素的数据.
主要成果:
- 在黑色素瘤类干细胞中,ABCB5α异型通过药物排放促进化学抵抗.
- 而ABCB5则影响PI3K/Akt,BCL-2和miR-145路径.
- 阳性ABCB5细胞通过分泌细胞因子和表达PD-L1.1,创造一个免疫抑制的微环境.
结论:
- 在黑色素瘤的进展和治疗耐药性方面,ABCB5发挥着重要作用.
- ABCB5有助于免疫抑制瘤微环境.
- 除了局限性之外,ABCB5在黑色素瘤中具有作为生物标志物和治疗点的潜力.
相关概念视频
Covalently Linked Protein Regulators
9.7K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
9.7K
Covalently Linked Protein Regulators
2.0K
2.0K
The Tumor Microenvironment
7.9K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.9K
Regulation of Hematopoietic Stem Cells
4.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.1K
Stem Cell Therapy for Tissue Regeneration
4.7K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.7K
Cancer Stem Cells and Tumor Maintenance
6.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K


